Integrated preclinical and clinical development of S-trans, trans-farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Combined Chemotherapy Protocols
  • Pancreatic Neoplasms

abstract

  • The combination of gemcitabine and salirasib appears well-tolerated, with no alteration of salirasib exposure, and exerted clinical and PD activity in PDA.

publication date

  • December 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3557459

Digital Object Identifier (DOI)

  • 10.1007/s10637-012-9818-6

PubMed ID

  • 22547163

Additional Document Info

start page

  • 2391

end page

  • 9

volume

  • 30

number

  • 6